Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
100 results
  1. Rectal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65965
    ... simultaneously with LV) were compared with the same 5-FU/LV regimen without oxaliplatin when administered for 6 months. Each ... analyzed the activity and toxic effects of various 5-FU/LV regimens using different doses and administration schedules and showed ...
  2. Colon Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65858
    ... LV/5-FU) were compared with the same 5-FU/LV regimen without oxaliplatin administered for 6 months.[ 25 ] Based ... analyzed the activity and toxic effects of various 5-FU/LV regimens using different doses and administration schedules and showed ...
  3. Systemic Therapy - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK82144
    ... platinum or platinum/taxane based regimens than with fluorouracil/anthracycline regimens, at the cost of greater treatment toxicity. Rationale ... platinum or platinum/taxane based regimens than with fluorouracil/anthracycline regimens (see Figures Table 23.2 and Table 23. ...
  4. Network Meta-Analysis (Mixed Treatment Comparison) and Economic Model on treatment of unresectable locally advanced ... 
    https://www.ncbi.nlm.nih.gov/books/NBK536651
    ... is mirrored by the PSA where again the 5-FU based regimens are rarely cost effective. The costs of gemcitabine are also now likely to be much reduced compared to those considered in TA25 ... The costs of gemcitabine and 5-FU are now likely to be very similar and ...
  5. Health economic evidence review - Oesophago-gastric cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK535638
    ... adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens (Structured abstract). Journal of Chemotherapy, 1995. 7, 455– ...
  6. Forest plots and Summary ROC curves - Pancreatic cancer in adults: diagnosis and management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536650
    ... 3/4 toxicities: Stomatitis H.17.6. Combination 5-FU (FSM) versus other chemotherapy regimens in adults with locally advanced or metastatic pancreatic ...
  7. Pancreatic Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65957
    ... the first-line treatment of metastatic pancreatic cancer. 5-FU, leucovorin, and oxaliplatin (OFF regimen) versus best supportive care (BSC): Second-line chemotherapy ...
  8. Esophageal Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65900
    ... chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer. Eur J Cancer 38 ( ...
  9. Breast Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... Chemotherapy Adjuvant chemotherapy 1970s to 2000: Anthracycline-based regimens versus cyclophosphamide, methotrexate, and 5-FU (CMF) The EBCTCG meta-analysis analyzed 11 trials ...
  10. What is the expected value of perfect information in reducing uncertainty surrounding the cost-effectiveness of ... 
    https://www.ncbi.nlm.nih.gov/books/NBK82153
    ... from the NHS Reference Costs. Intravenous administration of 5-FU and the carboplatin / paclitaxel combination regimen was assumed to be done on an outpatient ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last